The Evolving Understanding of Risk With CGRP mAbs The Evolving Understanding of Risk With CGRP mAbs

The authors explore potential adverse effects associated with CGRP monoclonal antibodies used for migraine prevention, highlighting some not currently noted in the package insert.Headache
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news